Home / Locations / Bioluminux Clinical Research New Jersey
Bioluminux Clinical Research New Jersey
About This Site
Our Hamilton, New Jersey site provides dedicated Phase 2–4 clinical research capabilities across CNS and psychiatric disorders, metabolic and cardiovascular disease, vaccines and infectious diseases, respiratory conditions, and general medicine.
Supported by experienced investigators and a dedicated research team, the site combines strong community and healthcare relationships with targeted patient recruitment and efficient study execution. Its strategic location provides access to diverse patient populations across Central New Jersey and the greater Philadelphia region, offering sponsors and CROs responsive site management, high-quality data, and dependable clinical trial delivery.
Research Leadership
Dr Matthew Adasofunjo MD, CFA, Board Certified Internal Medicine
Site Lead/Principal Investigator
Specialty:
Dr Olubukola Adasofunjo MD, Board Certified Adult/Child Psychiatrist, Paediatrician
Principal Investigator
Specialty:
Site Facilities & Amenities
Recruiting Studies At This Location
COPD and Common Colds Research Study
To investigate whether an antiviral medicine can reduce symptoms and COPD flare-ups caused by rhinovirus, a common cold virus.
Graves’ Disease (Overactive Thyroid) Research Study
To investigate whether a study treatment can maintain normal thyroid hormone levels without antithyroid medication, while assessing its safety.
Heart Rhythm, Artery Disease & Blood Clotting Research Study
To study blood clotting and blood markers in people with atrial fibrillation or artery disease over two years.